AbCellera Biologics Inc.
ABCL
$4.50
-$0.14-3.02%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
12/5/2023
-
Ticker Report
12/3/2023
-
Zolmax
12/1/2023
-
TipRanks Financial Blog
12/1/2023
-
Zolmax
11/30/2023
-
Ticker Report
11/29/2023
-
Seeking Alpha - Healthcare
11/29/2023
-
SeekingAlpha.com: All News
11/16/2023
-
Business Wire
11/13/2023
-
Zolmax
11/12/2023
-
Zolmax
11/11/2023
-
Zolmax
11/9/2023
-
Benzinga
11/8/2023
-
Zolmax
11/6/2023
-
Ticker Report
11/3/2023
-
Business Wire
11/3/2023
-
Fool.com Headlines
11/3/2023
-
Tickeron - Stocks
11/3/2023
-
SeekingAlpha
11/3/2023
-
Seeking Alpha: Transcripts
11/3/2023
-
TipRanks Financial Blog
11/2/2023
-
GuruFocus
11/2/2023
-
Business Wire
11/2/2023
-
Tickeron - Technical Analysis
11/1/2023
-
Business Wire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 2, 2023
Period Date
Saturday, September 30, 2023
Next Filing
Week of Feb 19 and 23 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
604-559-9005
Address
2215 Yukon Street
Vancouver, BC V5Y 0A1
Vancouver, BC V5Y 0A1
Country
Year Founded
Business Description
Sector
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The...
more